RTTNews | Jul 13, 2021 11:22AM EDT

11:21 Tuesday, July 13, 2021 (RTTNews.com) - Shares of Huize Holding Limited (HUIZ) are currently gaining over 4% after the Chinese digital insurance company announced that it has partnered with Sungrow to launch immune cell cryopreservation as a value-added healthcare service for eligible insurance customers.

HUIZ is currently trading at $5.42, up $0.21 or 4.03%, on the Nasdaq, on a volume of 2.4 million shares, above the average volume of 171 thousand. The stock has traded between $5.06 and $13.85 in the 52 weeks period.

The immune cell cryopreservation technology is supported by BGI Cell, and refers to the use of advanced biotechnology to extract immune cells from a healthy human body to be preserved at temperatures below 196C. These dormant cells can be reactivated in the future and are valuable for anti-aging, tissue regeneration, immune regulation, and other disease treatments.

Read the original article on RTTNews ( https://www.rttnews.com/3208760/huize-holding-gains-4-on-partnership-with-sungrow.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved